# Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability

> **NCT02002819** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 34 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** levetiracetam

## Key facts

- **NCT ID:** NCT02002819
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-16
- **Primary completion:** 2020-07-21
- **Final completion:** 2020-07-21
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002819, "Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02002819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*